TY - CHAP AU - Binder, G. AU - Bashe, P. PY - 2008 DA - 2008// BT - Science Lessons: What the Business of Biotech Taught Me About Management PB - Harvard Business School Press CY - Cambridge ID - Binder2008 ER - TY - CHAP AU - Feldman, M. AU - Colaianni, A. AU - Liu, K. PY - 2005 DA - 2005// BT - Commercializing Cohen-Boyer 1980-1997 PB - Kauffman Foundation CY - Kansas, USA ID - Feldman2005 ER - TY - CHAP AU - Pisano, G. PY - 2006 DA - 2006// BT - Science Business: The Promise, the Reality, and the Future of Biotech PB - Harvard Business School Press CY - Cambridge ID - Pisano2006 ER - TY - JOUR AU - Kumar, N. K. AU - Quach, U. AU - Thorsteinsdottir, H. AU - Somsekhar, H. AU - Daar, A. S. AU - Singer, P. A. PY - 2004 DA - 2004// TI - Indian biotechnology - rapidly evolving and industry led JO - Nature Biotechnology VL - 22 ID - Kumar2004 ER - TY - JOUR AU - Maiti, R. AU - Rahavendra, M. PY - 2007 DA - 2007// TI - Clinical trials in India JO - Pharmacological Research VL - 56 UR - https://doi.org/10.1016/j.phrs.2007.02.004 DO - 10.1016/j.phrs.2007.02.004 ID - Maiti2007 ER - TY - JOUR AU - Frew, S. E. AU - Rezaie, R. AU - Sammut, S. M. AU - Ray, M. AU - Daar, A. S. AU - Singer, P. A. PY - 2007 DA - 2007// TI - India's health biotech sector at a crossroads JO - Nature Biotechnology VL - 25 UR - https://doi.org/10.1038/nbt0407-403 DO - 10.1038/nbt0407-403 ID - Frew2007 ER - TY - JOUR AU - Ramani, S. V. PY - 2002 DA - 2002// TI - Who is interested in biotech? R&D strategies, knowledge base and market sales of Indian biopharmaceutical firms JO - Research Policy VL - 31 UR - https://doi.org/10.1016/S0048-7333(01)00115-9 DO - 10.1016/S0048-7333(01)00115-9 ID - Ramani2002 ER - TY - STD TI - Sanofi Pasteur. http://en.sanofi-aventis.com/binaries/20090727_shantha_control_en_tcm28-25746.pdf UR - http://en.sanofi-aventis.com/binaries/20090727_shantha_control_en_tcm28-25746.pdf ID - ref8 ER - TY - STD TI - Torsoli A: Sanofi agrees to take control of India's Shantha. http://www.bloomberg.com/apps/news?pid=20601202&sid=aLamsVEC7AUA UR - http://www.bloomberg.com/apps/news?pid=20601202&sid=aLamsVEC7AUA ID - ref9 ER - TY - CHAP AU - Yin, R. K. PY - 2003 DA - 2003// BT - Case Study Research: Design and Methods ID - Yin2003 ER - TY - JOUR AU - Al-Bader, S. AU - Masum, H. AU - Simiyu, K. AU - Daar, A. S. AU - Singer, P. A. PY - 2010 DA - 2010// TI - Science-based health innovation in sub-Saharan Africa JO - BMC Int Health Hum Rights VL - 10 UR - https://doi.org/10.1186/1472-698X-10-S1-S1 DO - 10.1186/1472-698X-10-S1-S1 ID - Al-Bader2010 ER - TY - JOUR AU - Chakma, J. AU - Masum, H. AU - Perampaladas, K. AU - Heys, J. AU - Singer, P. A. PY - 2010 DA - 2010// TI - India's Billion Dollar Biotech JO - Nature Biotechnology VL - 28 UR - https://doi.org/10.1038/nbt0810-783 DO - 10.1038/nbt0810-783 ID - Chakma2010 ER - TY - STD TI - World Health Organization Country Office for India: Introducing Hepatitis B Under Universal Immunization: Frequently Asked Questions. http://www.whoindia.org/EN/Section6/Section8_26.htm 10.1038/nbt0810-783 UR - http://www.whoindia.org/EN/Section6/Section8_26.htm ID - ref13 ER - TY - CHAP AU - Frost, L. J. AU - Reich, M. R. PY - 2009 DA - 2009// BT - Access: How do good health technologies get to poor people in poor countries? PB - Harvard University Press CY - Cambridge ID - Frost2009 ER - TY - STD TI - UNICEF. http://www.unicef.org/infobycountry/india_statistics.html UR - http://www.unicef.org/infobycountry/india_statistics.html ID - ref15 ER - TY - JOUR AU - Shekhar, C. PY - 2008 DA - 2008// TI - Pischia Power: India's Biotech Industry Puts Unconventional Yeast to Work JO - Chemistry & Biology VL - 15 UR - https://doi.org/10.1016/j.chembiol.2008.03.002 DO - 10.1016/j.chembiol.2008.03.002 ID - Shekhar2008 ER - TY - STD TI - Revathi C: Meeting of Commission of Intellectual Property Rights, Innovation & Public Health. http://www.who.int/intellectualproperty/events/en/Revathi.pdf UR - http://www.who.int/intellectualproperty/events/en/Revathi.pdf ID - ref17 ER - TY - STD TI - Financial Express: Shantha Biotech Plans To Raise $25 Million. http://www.financialexpress.com/news/shantha-biotech-plans-to-raise-25-million/52289 UR - http://www.financialexpress.com/news/shantha-biotech-plans-to-raise-25-million/52289 ID - ref18 ER - TY - JOUR AU - Acharya, T. AU - Kumar, N. K. AU - Muthuswamy, V. AU - Daar, A. S. AU - Singer, P. A. PY - 2004 DA - 2004// TI - "Harnessing genomics to improve health in India" - an executive course to support genomics policy JO - Health Res Policy Syst VL - 2 UR - https://doi.org/10.1186/1478-4505-2-1 DO - 10.1186/1478-4505-2-1 ID - Acharya2004 ER - TY - STD TI - Government of India. http://india.gov.in/citizen/health/hepatitis.php UR - http://india.gov.in/citizen/health/hepatitis.php ID - ref20 ER - TY - STD TI - Bloomberg News: Sanofi Agrees to take Control of India's Shantha. http://www.bloomberg.com/apps/news?pid=20601091&sid=aHyZdTO4KkGc UR - http://www.bloomberg.com/apps/news?pid=20601091&sid=aHyZdTO4KkGc ID - ref21 ER - TY - STD TI - World Intellectual Property Organization: A Process for the Production of Human Interferon Alpha from Genetically Engineered Yeast. http://www.wipo.int/pctdb/en/wo.jsp?wo=2001068827 UR - http://www.wipo.int/pctdb/en/wo.jsp?wo=2001068827 ID - ref22 ER - TY - JOUR AU - Natesh, S. AU - Bhan, M. K. PY - 2009 DA - 2009// TI - Biotechnology sector in India: strengths, limitations, remedies and outlook JO - Current Science VL - 2 ID - Natesh2009 ER - TY - STD TI - Business Standard: Shantha Bio launches its 4th r-DNA product. http://www.business-standard.com/india/news/shantha-bio-launches-its-4th-r-dna-product/199864/ UR - http://www.business-standard.com/india/news/shantha-bio-launches-its-4th-r-dna-product/199864/ ID - ref24 ER - TY - STD TI - World Health Organization. http://www.who.int/immunization_standards/vaccine_quality/pq_suppliers/en UR - http://www.who.int/immunization_standards/vaccine_quality/pq_suppliers/en ID - ref25 ER - TY - STD TI - Shantha Biotech: Research & Development: Pipeline. http://www.shanthabiotech.com/pipe_line.htm UR - http://www.shanthabiotech.com/pipe_line.htm ID - ref26 ER - TY - STD TI - Shantha Biotech: Corporate Presentation. http://www.shanthabiotech.com/corporate_film/presentation.pps UR - http://www.shanthabiotech.com/corporate_film/presentation.pps ID - ref27 ER - TY - STD TI - Shantha Biotech: Research & Development. http://www.shanthabiotech.com/rd_overview.htm UR - http://www.shanthabiotech.com/rd_overview.htm ID - ref28 ER - TY - STD TI - PATH. http://www.path.org/projects/rotavirus_vaccine_projects.php UR - http://www.path.org/projects/rotavirus_vaccine_projects.php ID - ref29 ER - TY - STD TI - Centre for Cellular & Molecular Biology. http://www.ccmb.res.in/ UR - http://www.ccmb.res.in/ ID - ref30 ER - TY - CHAP AU - Pantulu, C. C. PY - 1998 DA - 1998// TI - Shantha Biotechnics accuses SmithKline of indulging in unfair practices BT - Financial Express ID - Pantulu1998 ER - TY - JOUR AU - Abraham, P. AU - Mistry, F. P. AU - Bapat, M. R. AU - Sharma, G. AU - Reddy, G. R. AU - Prasad, K. S. N. AU - Ramanna, V. PY - 1999 DA - 1999// TI - Evaluation of a New Recombinant DNA Hepatitis B Vaccine (Shanvac-B) JO - Vaccine VL - 17 UR - https://doi.org/10.1016/S0264-410X(98)00331-4 DO - 10.1016/S0264-410X(98)00331-4 ID - Abraham1999 ER - TY - STD TI - Motwani N: Biosimilars Jumpstart Biotech in India. Genetic Engineering & Biotechnology News. 2007, 27 (8): ID - ref33 ER - TY - CHAP PY - 2007 DA - 2007// TI - National Biotechnology Development Strategy: Key Elements BT - Delhi ID - ref34 ER - TY - CHAP AU - Rao, S. R. PY - 2007 DA - 2007// TI - Indian biotechnology developments in public and private sectors - status and opportunities BT - Asian Biotechnology and Development Review ID - Rao2007 ER - TY - CHAP PY - 2009 DA - 2009// BT - Big drug firms embrace generics: friends for life ID - ref36 ER - TY - STD TI - International Vaccine Institute. http://www.ivi.org/program/tr_domi_cholera.html UR - http://www.ivi.org/program/tr_domi_cholera.html ID - ref37 ER - TY - CHAP PY - 2009 DA - 2009// BT - World's first low-cost cholera vaccine licensed in India ID - ref38 ER - TY - CHAP PY - 2009 DA - 2009// BT - Sanofi buys Indian vaccine firm ID - ref39 ER - TY - CHAP AU - Margolis, H. S. PY - 2008 DA - 2008// BT - Pediatric Dengue Vaccine in the Americas ID - Margolis2008 ER - TY - STD TI - Shantha Biotech. http://www.shanthabiotech.com/news_9.htm UR - http://www.shanthabiotech.com/news_9.htm ID - ref41 ER - TY - STD TI - Sanofi-Aventis. http://www.shanthabiotech.com/Shantha_UN%20Order-Sep09.pdf UR - http://www.shanthabiotech.com/Shantha_UN%20Order-Sep09.pdf ID - ref42 ER - TY - CHAP AU - Martino, M. PY - 2009 DA - 2009// BT - Rumor: GSK close to deal for Shantha Biotech ID - Martino2009 ER - TY - CHAP AU - Prahalad, C. K. PY - 2004 DA - 2004// BT - The fortune at the bottom of the pyramid: eradicating poverty through profits PB - Wharton School Publishing CY - Philadelphia ID - Prahalad2004 ER - TY - CHAP AU - Hammond, A. L. AU - Kramer, W. J. AU - Katz, R. S. AU - Tran, J. T. AU - Walker, C. PY - 2007 DA - 2007// BT - The Next 4 Billion: Market Size and Business Strategy at the Base of the Pyramid PB - World Bank Group CY - Washington DC ID - Hammond2007 ER - TY - CHAP AU - Patel, P. AU - D'Souza, R. PY - 2008 DA - 2008// BT - Uncovering Knowledge Structures of Venture Capital Investment Decision Making PB - The Office of Advocacy of the U.S. Small Business Administration CY - Washington ID - Patel2008 ER - TY - CHAP AU - Jadhav, S. S. AU - Gautam, M. AU - Gairola, S. PY - 2009 DA - 2009// TI - Emerging markets & emerging needs: developing countries vaccine manufacturers' perspective & its current status BT - Biologicals ID - Jadhav2009 ER - TY - STD TI - Intel. http://www.intel.com/technology/tick-tock/index.htm UR - http://www.intel.com/technology/tick-tock/index.htm ID - ref48 ER - TY - JOUR AU - Chaturvedi, K. AU - Chataway, J. PY - 2006 DA - 2006// TI - Strategic integration of knowledge in Indian pharmaceutical firms: creating competencies for innovation JO - International Journal of Business Innovation and Research VL - 1 UR - https://doi.org/10.1504/IJBIR.2006.011087 DO - 10.1504/IJBIR.2006.011087 ID - Chaturvedi2006 ER - TY - CHAP AU - Crabtree, P. PY - 2005 DA - 2005// TI - An East-West Team BT - San Diego Union-Tribune ID - Crabtree2005 ER - TY - JOUR AU - Maiti, R. AU - Raghavendra, M. PY - 2007 DA - 2007// TI - Clinical trials in India JO - Pharmacological Research VL - 56 UR - https://doi.org/10.1016/j.phrs.2007.02.004 DO - 10.1016/j.phrs.2007.02.004 ID - Maiti2007 ER - TY - JOUR AU - Chakma, J. AU - Calcagno, J. L. AU - Behbahani, A. AU - Mojtahedian, S. PY - 2009 DA - 2009// TI - Is it Virtuous to be Virtual? The VC Viewpoint JO - Nature Biotechnology VL - 27 UR - https://doi.org/10.1038/nbt1009-886 DO - 10.1038/nbt1009-886 ID - Chakma2009 ER - TY - CHAP AU - Milstien, J. B. AU - Kaddar, M. PY - 2010 DA - 2010// TI - The role of emerging manufacturers in access to innovative vaccines of public health importance BT - Vaccine ID - Milstien2010 ER - TY - JOUR AU - Frew, S. E. AU - Kettler, H. E. AU - Singer, P. A. PY - 2008 DA - 2008// TI - The Indian and Chinese Health Biotechnology Industries: Potential Champions of Global Health? JO - Health Affairs VL - 27 UR - https://doi.org/10.1377/hlthaff.27.4.1029 DO - 10.1377/hlthaff.27.4.1029 ID - Frew2008 ER - TY - JOUR AU - Sundaramoorthy, S. AU - Bindu, Y. C. AU - Mehdiratta, R. AU - Saberwal, G. PY - 2009 DA - 2009// TI - The US patent holdings of homegrown Indian biotech and pharma companies JO - Current Science VL - 96 ID - Sundaramoorthy2009 ER - TY - CHAP AU - Nauriyal, D. K. PY - 2007 DA - 2007// TI - TRIPS-Compliant New Patents Act and Indian Pharmaceutical Sector Directions in Strategy and R&D BT - Indian Journal of Economics & Business ID - Nauriyal2007 ER - TY - JOUR AU - Kettler, H. E. AU - Modi, R. PY - 2001 DA - 2001// TI - Building local research and development capacity for the prevention and cure of neglected disease and cure of neglected diseases: the case of India JO - Bull. World Health Organ VL - 79 ID - Kettler2001 ER - TY - JOUR AU - Milstien, J. AU - Kaddar, M. PY - 2006 DA - 2006// TI - Managing the effect of TRIPS on availability of priority vaccines JO - Bulletin of the World Health Organization VL - 84 UR - https://doi.org/10.2471/BLT.05.028431 DO - 10.2471/BLT.05.028431 ID - Milstien2006 ER - TY - JOUR AU - Milstien, J. PY - 2009 DA - 2009// TI - Challenges and potential solutions to innovative vaccine development for developing countries JO - Proceedia in Vaccinology VL - 1 UR - https://doi.org/10.1016/j.provac.2009.07.031 DO - 10.1016/j.provac.2009.07.031 ID - Milstien2009 ER - TY - JOUR AU - Rezaie, R. AU - Singer, P. A. PY - 2010 DA - 2010// TI - Global health or global wealth? JO - Nature Biotechnology VL - 28 UR - https://doi.org/10.1038/nbt0910-907 DO - 10.1038/nbt0910-907 ID - Rezaie2010 ER -